Lucie Biard Selected Research

Brentuximab Vedotin

11/2019

Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucie Biard Research Topics

Disease

9	Neoplasms (Cancer) 11/2023 - 01/2017
4	Infections 01/2022 - 12/2017
3	COVID-19 05/2024 - 01/2021
3	Takayasu Arteritis (Arteritis, Takayasu's) 10/2023 - 11/2022
3	Uveitis 01/2022 - 01/2016
3	Vasculitis (Vasculitides) 01/2022 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 01/2019
2	Macular Edema 01/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 11/2019
2	Cryoglobulinemia 01/2020 - 01/2020
2	Sarcoidosis (Schaumann Disease) 12/2017 - 07/2015
1	Fusariosis 02/2024
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2023
1	Aortic Dissection 12/2023
1	Aneurysm (Aneurysms) 12/2023
1	Aortitis 12/2023
1	Pyoderma Gangrenosum 01/2023
1	CADASIL 01/2023
1	Retinal Vasculitis 01/2022
1	Stroke (Strokes) 01/2022
1	Low Vision (Subnormal Vision) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Myocardial Infarction 01/2022
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Pancreatitis 01/2022
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022
1	Shock 06/2021
1	Hematologic Diseases (Blood Diseases) 06/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2021
1	Bacteremia 01/2021
1	Disease Progression 01/2021
1	Atrioventricular Block 01/2020
1	Lymphoma (Lymphomas) 11/2019
1	Burns 02/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Pelvic Neoplasms 11/2018
1	Sepsis (Septicemia) 11/2018
1	Breast Neoplasms (Breast Cancer) 03/2018
1	Peritonitis 01/2017
1	Adenocarcinoma 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

3	tocilizumab (atlizumab)FDA Link 01/2023 - 01/2022
3	Infliximab (Remicade)FDA Link 01/2022 - 07/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2016
2	CytokinesIBA 05/2024 - 01/2021
2	Rituximab (Mabthera)FDA Link 10/2023 - 01/2020
2	InterferonsIBA 01/2022 - 01/2022
2	Adalimumab (Humira)FDA Link 01/2022 - 01/2016
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	CryoglobulinsIBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024
1	Voriconazole (Vfend)FDA LinkGeneric 02/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	N 30IBA 12/2023
1	Drug CombinationsIBA 11/2023
1	HS 6 (HS-6)IBA 01/2023
1	Notch3 ReceptorIBA 01/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	mogamulizumabIBA 01/2022
1	SteroidsIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Oxygen (Dioxygen)IBA 06/2021
1	AnticoagulantsIBA 04/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	GadoliniumIBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	AntibodiesIBA 11/2019
1	Brentuximab VedotinIBA 11/2019
1	CreatinineIBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	Phenobarbital (Luminal)FDA Link 03/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2017
1	Anaplastic Lymphoma KinaseIBA 01/2017
1	liquid crystal polymerIBA 01/2017

Therapy/Procedure

6	Therapeutics 02/2024 - 01/2016
6	Drug Therapy (Chemotherapy) 12/2022 - 01/2015
4	Immunotherapy 12/2022 - 01/2017
2	Hematopoietic Stem Cell Transplantation 02/2024 - 01/2017
2	Stem Cell Transplantation 02/2024 - 11/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2019 - 01/2017
2	Neoadjuvant Therapy 03/2018 - 04/2016
1	Organ Transplantation 06/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Length of Stay 02/2019
1	Catheters 02/2019